“non-small-cell-lung-cancer” Archives

in
Entry Author Date Location
Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout 09/14/20 San Francisco
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures 09/05/20 Boston
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug 05/08/20 Indiana
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic 03/02/20 Boston
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers 01/17/20 San Francisco
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test 10/16/19 Indiana
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck 07/24/19 New York
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
TCR²’s IPO Raises $75M to Bring Cancer Cell Therapy to Solid Tumors 02/14/19 Boston
In Another Lung Cancer Setback, Bristol Yanks FDA App For Drug Combo 01/24/19 New York
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Mirati Shares Fall On New Data For Lung Cancer Drug Combo 10/23/18 San Diego
Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up 10/12/18 New York
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer 08/17/18 New York
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results 05/29/18 San Francisco
Ahead of ASCO, Merck Touts Another Win for Lung Cancer Drug Combo 05/23/18 New York
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer 04/24/18 San Francisco
With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace 04/11/18 National
Page 1 of 2 next page »